Ghrelin therapy increased ERK activation and suppressed JNK activation in ileum, and decreased intestinal injury after radiation injury combined wound (CI) [43]; in brain haemorrhage induced by CI, Ghrelin therapy with pegylated G-CSF significantly mitigated ERK1/2 and JNK activation [44]. The gene discussed is MAPK8; the disease is intracranial hemorrhage.